EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC-ND 4.0

Salivary Gland Secretory Carcinoma; Review of 13 Years World‐Wide Experience and Meta‐Analysis

Eyal Yosefof iD, Tomer Boldes, Daniel Dan, Eyal Robenshtok, Yulia Strenov, Gideon Bachar, Thomas Shpitzer, Aviram Mizrachi iD

The Laryngoscope · 2024-04 · 134 (4) · 1716-1724

DOI: 10.1002/lary.31123 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Laryngoscope, 2023-11. Verfasst von Eyal Yosefof und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Adenocarcinoma, Carcinoma, Breast Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Secretory Carcinoma is a malignant salivary gland tumor, initially described in 2010. This rare tumor is associated with the translocation t(12;15) (p13;q25), resulting in the fusion gene ETV6‐NTRK3. Since this tumor is quite rare, most publications describe only small cohorts of patients. We aimed to investigate the clinical, pathological, and prognostic features of this newly defined malignant entity. Data Sources Pubmed, Google Scholar, and Web of Science databases. Review Methods All published articles between 2010 and 2023 were reviewed. Search terms included the terms “Mammary Analogue Secretory Carcinoma” and “Secretory Carcinoma”. All articles published in English reporting on Secretory Carcinoma of salivary glands were retrieved.

Results

One‐hundred and 12 retrospective articles reporting a total of 674 patients were included, with 52% males and a mean age of 44.9 ± 18.9. The event rate for patients with advanced‐stage disease (Stage 3/4) at presentation was 24.1% (95% CI 17.6%–31.9%, I 2 = 9.2%), 14.6% for regional metastases (95% CI 10.5%–20%, I 2 = 12%), and the event rate of distant metastasis was 8.4% (95% CI 5.5%–12.7%, I 2 = 4.2%). Adjuvant radiotherapy was administered for 30.3% of patients (95% CI 24.1%–37.2%, I 2 = 21.5%). The recurrence rate was 19% (95% CI 15.1%–23.8%, I 2 = 5%). Survival outcomes showed a 17.2% death of disease rate for Secretory Carcinoma patients (95% CI 13.5%–21.8%, I 2 = 7.3%).

Conclusions

Secretory Carcinoma is a rare and relatively newly defined entity arising in the parotid gland most commonly. Characterized as a low‐grade tumor, the majority of patients are diagnosed at an early stage, without regional or distant disease, and the prognosis is relatively good. Level of Evidence NA Laryngoscope , 134:1716–1724, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsAdenocarcinomaCarcinomaBreast NeoplasmsMaleHumansAdultMiddle AgedFemaleRetrospective StudiesBiomarkers, TumorOncogene Proteins, FusionSalivary Glands

Stichwörter der Autor:innen

low-grade tumorsalivary gland tumorsecretory carcinoma

Substanzen

Biomarkers, TumorOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Otorhinolaryngology and Head and Neck Surgery, Rabin Medical Center-Beilinson Hospital, Petach Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Institute of Endocrinology, Diabetes and Metabolism, Rabin Medical Center, Petah Tikva, Israel.
  • Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.

ORCID-Profile: Eyal Yosefof, Aviram Mizrachi

Zitieren

APA

Yosefof, E., Boldes, T., Dan, D., Robenshtok, E., Strenov, Y., Bachar, G., Shpitzer, T., & Mizrachi, A. (2024). Salivary Gland Secretory Carcinoma; Review of 13 Years World‐Wide Experience and Meta‐Analysis. The Laryngoscope, 134(4), 1716-1724. https://doi.org/10.1002/lary.31123

Vancouver

Yosefof E, Boldes T, Dan D, Robenshtok E, Strenov Y, Bachar G, et al. Salivary Gland Secretory Carcinoma; Review of 13 Years World‐Wide Experience and Meta‐Analysis. The Laryngoscope. 2024;134(4):1716-1724. doi:10.1002/lary.31123

BibTeX
@article{Yosefof2024,
  author = {Yosefof, Eyal and Boldes, Tomer and Dan, Daniel and Robenshtok, Eyal and Strenov, Yulia and Bachar, Gideon and Shpitzer, Thomas and Mizrachi, Aviram},
  title = {Salivary Gland Secretory Carcinoma; Review of 13 Years World‐Wide Experience and Meta‐Analysis},
  journal = {The Laryngoscope},
  year = {2024},
  volume = {134},
  number = {4},
  pages = {1716--1724},
  doi = {10.1002/lary.31123}
}
Kostenlos starten →